Company profile: NanoCures
1.1 - Company Overview
Company description
- Provider of clinical-stage biotechnology and infectious disease immunity platforms, including: Cures Platform targeting specific genomic and molecular pathways to yield multiple therapeutics; Data/AI Platform using biometric, genomic, molecular, and environmental data with AI/ML to detect diseases early and guide new cure development; and Developer Platform offering resources, data, and tools to lower barriers and encourage innovation.
Products and services
- Data/AI Platform: AI/ML-driven system utilizing biometric, genomic, molecular, and environmental data to detect diseases early and guide new cure development
- Cures Platform: Custom-engineered platform targeting specific genomic and molecular pathways causing disease, producing multiple therapeutics aligned to those pathways
- Developer Platform: Modular platform offering resources, data, and tools to institutions and individual developers, lowering barriers and encouraging new cure innovation
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to NanoCures
Earth Science Tech
HQ: United States
Website
- Description: Provider of science-based biotechnology offerings bringing Nature's Pharmacy to the public, operating RxCompoundStore, a Miami compounding pharmacy licensed in 23 states; Peaks Curative, a telemedicine platform for men's and women's health offering ED products via a proprietary tadalafil gummy; Avenvi, a Miami real estate development firm; and Mister Meds, a Texas wellness-focused pharmacy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Earth Science Tech company profile →
Emergent BioSolutions
HQ: United States
Website
- Description: Provider of medical countermeasures for biological and chemical threats, developing, manufacturing, and delivering products including NARCAN® Nasal Spray to rapidly reverse opioid overdose; BioThrax® and CYFENDUS™ anthrax vaccines; ACAM2000® smallpox vaccine; TEMBEXA® antiviral for smallpox; and EbangaTM therapeutic antibody for Ebola virus infection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Emergent BioSolutions company profile →
T2 Biosystems
HQ: United States
Website
- Description: Provider of rapid, accurate infectious disease diagnostics, including the T2Dx Instrument, a fully automated system running tests directly from whole blood, the FDA-cleared T2Bacteria Panel for identifying sepsis-causing bacteria without blood culture, and T2Candida for detecting invasive candidiasis from whole blood.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full T2 Biosystems company profile →
Marinomed Biotech
HQ: Austria
Website
- Description: Provider of a moisturizing film that comforts dry eyes and helps prevent allergens, formulated with ingredients for the prevention and treatment of viral respiratory illnesses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Marinomed Biotech company profile →
TriPharm
HQ: United States
Website
- Description: Provider of pharmaceuticals as a privately held pharmaceuticals company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TriPharm company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for NanoCures
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to NanoCures
2.2 - Growth funds investing in similar companies to NanoCures
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for NanoCures
4.2 - Public trading comparable groups for NanoCures
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →